Streetbeat News

VRNOF

Verano Holdings Corp

Industry

Pharmaceutical Preparation Manufacturing

Open

0.65

Mkt cap

233M

Volume

47K

High

0.68

P/E Ratio

-0.66

52-wk high

6.50

Low

0.65

Div yield

N/A

52-wk low

0.60

Verano Holdings Corporation (VRNOF) held its Q3 2024 earnings conference call, discussing financial results and company performance. Key participants included company executives and analysts from various financial institutions.

Portfolio Pulse from

November 09, 2024 | 7:00 pm

Verano Holdings Corp. (VRNOF) reported a Q3 loss of $0.12 per share, missing the Zacks Consensus Estimate of a $0.03 loss. This is a significant increase in loss compared to the $0.03 per share loss from the previous year.

Portfolio Pulse from

November 07, 2024 | 4:30 pm

Verano Holdings Corp. announced its Q3 2024 financial results, prepared according to U.S. GAAP. The company is a leading multi-state cannabis operator.

Portfolio Pulse from

November 07, 2024 | 11:15 am

Verano Holdings Corp. (VRNOF) is expected to surpass earnings estimates in its upcoming report, indicating a potential positive impact on its stock price.

Portfolio Pulse from

November 06, 2024 | 4:30 pm

Florida's cannabis market is poised for significant changes with the upcoming recreational cannabis vote. The market is experiencing deflation, with sales dropping despite volume growth, and a competitive landscape is emerging. Key players like Trulieve, Verano, and AYR are expanding retail operations, while M&A activity is expected to increase. Companies like AYR and iAnthus may become acquisition targets due to financial challenges, while others like Green Thumb and Curaleaf are positioned to acquire assets. If recreational cannabis is legalized, the market could triple, offering substantial growth opportunities.

Portfolio Pulse from Nicolás Jose Rodriguez

October 26, 2024 | 6:15 pm

A federal appellate court will hear a case challenging the U.S. government's prohibition on marijuana, filed by Verano Holdings and other cannabis businesses. The case argues that federal prohibition is unconstitutional given state-regulated cannabis activities. The hearing is set for December 5.

Portfolio Pulse from Juan Spínelli

October 25, 2024 | 3:35 am

Pennsylvania's GOP districts are increasingly supporting cannabis legalization due to economic distress, poverty, and the opioid crisis. This bipartisan support is seen as a potential solution for economic growth and harm reduction. The trend could serve as a model for other conservative states. Several cannabis companies, including Jushi Holdings, Cresco Labs, Green Thumb Industries, Verano Holdings, and Trulieve Cannabis, could benefit from potential legalization.

Portfolio Pulse from Nicolás Jose Rodriguez

October 16, 2024 | 1:33 am

Cannabis sales in Colorado have increased by 5% quarter-to-date, while Connecticut's sales remain flat year-over-year. Notable companies in these markets include Schwazze, The Cannabist Company, Curaleaf, Green Thumb Industries, Trulieve Cannabis, and Verano Holdings.

Portfolio Pulse from Nicolás Jose Rodriguez

October 15, 2024 | 12:41 am

The U.S. Department of Justice is urging a federal appeals court to uphold the federal cannabis ban, despite state-level legalizations. The case, led by Canna Provisions Inc. and supported by Verano Holdings, challenges the Controlled Substances Act. Attorney David Boies argues for reexamination due to changing regulations and enforcement policies.

Portfolio Pulse from Rolando García

October 14, 2024 | 3:01 am

The Benzinga Cannabis Capital Conference highlighted optimism in the cannabis industry, focusing on potential federal reforms like rescheduling and the SAFE Banking Act. Key industry leaders discussed the impact of these changes on taxation and banking access, with companies like Verano, Curaleaf, and Cresco Labs positioning for growth. The conference emphasized the importance of adaptability and technological innovation in the evolving market.

Portfolio Pulse from Javier Hasse

October 11, 2024 | 6:38 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.